These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 3629206

  • 1. Hepatotoxicity associated with low-dose, long-term methotrexate treatment of rheumatoid arthritis.
    Szanto E, Sandstedt B, Kollberg B.
    Scand J Rheumatol; 1987; 16(4):229-34. PubMed ID: 3629206
    [Abstract] [Full Text] [Related]

  • 2. Low incidence of hepatotoxicity associated with long-term, low-dose oral methotrexate in treatment of refractory psoriasis, psoriatic arthritis, and rheumatoid arthritis. An acceptable risk/benefit ratio.
    Lanse SB, Arnold GL, Gowans JD, Kaplan MM.
    Dig Dis Sci; 1985 Feb; 30(2):104-9. PubMed ID: 3967557
    [Abstract] [Full Text] [Related]

  • 3. Histopathologic findings in the liver of rheumatoid arthritis patients treated with long-term bolus methotrexate.
    Aponte J, Petrelli M.
    Arthritis Rheum; 1988 Dec; 31(12):1457-64. PubMed ID: 3196364
    [Abstract] [Full Text] [Related]

  • 4. Hepatotoxicity of prolonged methotrexate therapy for rheumatoid arthritis.
    Mackenzie AH.
    Cleve Clin Q; 1985 Dec; 52(2):129-35. PubMed ID: 4028418
    [No Abstract] [Full Text] [Related]

  • 5. Massive intrahepatic hemorrhage following routine liver biopsy in a patient with rheumatoid arthritis treated with methotrexate.
    Cash JM, Swain M, Di Bisceglie AM, Wilder RL, Crofford LJ.
    J Rheumatol; 1992 Sep; 19(9):1466-8. PubMed ID: 1433018
    [Abstract] [Full Text] [Related]

  • 6. Non-alcoholic steatohepatitis-like pattern in liver biopsy of rheumatoid arthritis patients with persistent transaminitis during low-dose methotrexate treatment.
    Mori S, Arima N, Ito M, Fujiyama S, Kamo Y, Ueki Y.
    PLoS One; 2018 Sep; 13(8):e0203084. PubMed ID: 30142184
    [Abstract] [Full Text] [Related]

  • 7. Association between cumulative methotrexate dose, non-invasive scoring system and hepatic fibrosis detected by Fibroscan in rheumatoid arthritis patients receiving methotrexate.
    Lertnawapan R, Chonprasertsuk S, Siramolpiwat S.
    Int J Rheum Dis; 2019 Feb; 22(2):214-221. PubMed ID: 30565876
    [Abstract] [Full Text] [Related]

  • 8. Liver biopsy findings in patients with rheumatoid arthritis undergoing longterm treatment with methotrexate.
    Rau R, Karger T, Herborn G, Frenzel H.
    J Rheumatol; 1989 Apr; 16(4):489-93. PubMed ID: 2473207
    [Abstract] [Full Text] [Related]

  • 9. "Hepatic toxicity by methotrexate with weekly single doses associated with folic acid in rheumatoid and psoriatic arthritis. What is its real frequency?".
    García DS, Saturansky EI, Poncino D, Martínez-Artola Y, Rosenberg S, Abritta G, Ascimani-Peña C, Cravero A.
    Ann Hepatol; 2019 Apr; 18(5):765-769. PubMed ID: 31105018
    [Abstract] [Full Text] [Related]

  • 10. The value of dynamic hepatic scintigraphy and serum aminoterminal propeptide of type III procollagen for early detection of methotrexate-induced hepatic damage in psoriasis patients.
    vanDooren-Greebe RJ, Kuijpers AL, Buijs WC, Kniest PH, Corstens FH, Nagengast FM, de Boo T, Willems JL, Duller P, van de Kerkhof PC.
    Br J Dermatol; 1996 Mar; 134(3):481-7. PubMed ID: 8731673
    [Abstract] [Full Text] [Related]

  • 11. Hepatotoxicity of methotrexate in rheumatic diseases.
    Kevat S, Ahern M, Hall P.
    Med Toxicol Adverse Drug Exp; 1988 Mar; 3(3):197-208. PubMed ID: 3041245
    [Abstract] [Full Text] [Related]

  • 12. Liver cirrhosis in rheumatoid arthritis patients treated with long-term methotrexate.
    Minocha A, Dean HA, Pittsley RA.
    Vet Hum Toxicol; 1993 Feb; 35(1):45-8. PubMed ID: 8434456
    [Abstract] [Full Text] [Related]

  • 13. [Methotrexate, liver and rheumatoid arthritis in tropical areas].
    Diouf ML, Diallo S, Mbengue M, Moreira-Diop T.
    Sante; 2001 Feb; 11(3):195-200. PubMed ID: 11641084
    [Abstract] [Full Text] [Related]

  • 14. Longterm methotrexate therapy in rheumatoid arthritis: a review.
    Kremer JM.
    J Rheumatol Suppl; 1985 Dec; 12 Suppl 12():25-8. PubMed ID: 3913773
    [Abstract] [Full Text] [Related]

  • 15. Light and electron microscopic analysis of liver biopsy samples from rheumatoid arthritis patients receiving long-term methotrexate therapy.
    Ros S, Juanola X, Condom E, Cañas C, Riera J, Guardiola J, Del Blanco J, Rebasa P, Valverde J, Roig-Escofet O.
    Scand J Rheumatol; 2002 Dec; 31(6):330-6. PubMed ID: 12492247
    [Abstract] [Full Text] [Related]

  • 16. Clinical liver disease in patients with rheumatoid arthritis taking methotrexate.
    Phillips CA, Cera PJ, Mangan TF, Newman ED.
    J Rheumatol; 1992 Feb; 19(2):229-33. PubMed ID: 1629819
    [Abstract] [Full Text] [Related]

  • 17. Usefulness of the American College of Rheumatology recommendations for liver biopsy in methotrexate-treated rheumatoid arthritis patients.
    Erickson AR, Reddy V, Vogelgesang SA, West SG.
    Arthritis Rheum; 1995 Aug; 38(8):1115-9. PubMed ID: 7639808
    [Abstract] [Full Text] [Related]

  • 18. Methotrexate use in rheumatoid arthritis is associated with few clinically significant liver function test abnormalities.
    Yazici Y, Erkan D, Harrison MJ, Nikolov NP, Paget SA.
    Clin Exp Rheumatol; 2005 Aug; 23(4):517-20. PubMed ID: 16095122
    [Abstract] [Full Text] [Related]

  • 19. Methotrexate for rheumatoid arthritis. Suggested guidelines for monitoring liver toxicity. American College of Rheumatology.
    Kremer JM, Alarcón GS, Lightfoot RW, Willkens RF, Furst DE, Williams HJ, Dent PB, Weinblatt ME.
    Arthritis Rheum; 1994 Mar; 37(3):316-28. PubMed ID: 8129787
    [Abstract] [Full Text] [Related]

  • 20. Significance of liver biopsy for the evaluation of methotrexate-induced liver damage in patients with rheumatoid arthritis.
    Osuga T, Ikura Y, Kadota C, Hirano S, Iwai Y, Hayakumo T.
    Int J Clin Exp Pathol; 2015 Mar; 8(2):1961-6. PubMed ID: 25973089
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.